LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $60.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $665.9K | 1.1% |
| Business Acquisitions | $33.3M | 54.8% |
| Stock Repurchases | $2.2M | 3.6% |
| Other | $24.6M | 40.5% |
| Net Cash Flow | $0 | 0.0% |